Carl Zeiss Meditec AG (AFX MU) stock market data APIs
€47.2121
0(0%)
as of October 21, 2025
Try our APIs with
free plan!
Carl Zeiss Meditec AG Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for AFX.MU.
Prev. Close
47.2121
Open
47.2121
High
47.2121
Low
47.2121
52 wk Range
40.9-68.7974
Market Cap
15 294 M
EPS
0.52
Dividends (Yield)
0.0093
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Carl Zeiss Meditec AG data using free add-ons & libraries
Get Carl Zeiss Meditec AG Fundamental Data
Carl Zeiss Meditec AG Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-13
- EPS/Forecast: 0.46
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Carl Zeiss Meditec AG News
New
Investors Could Be Concerned With Carl Zeiss Meditec's (ETR:AFX) Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? In a perfect world, we'd like to see a company investing more capital into its bus...
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
Showcasing at AAO 2025: NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with...
Carl Zeiss Meditec AG's (ETR:AFX) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Carl Zeiss Meditec (ETR:AFX) has had a rough three months with its share price down 19%. However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with futur...
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones
ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at ESCRS from Sept. 12 - 15 in Copenhagen, Denmark: EFFICIENT, CONFIDENT DECISION MAKING: introducing AI-powere...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
